Patriot Scientific Corp (PTSC) financial statements (2021 and earlier)

Company profile

Business Address 2038 CORTE DEL NOGAL, SUITE 141
CARLSBAD, CA 92011-1478
State of Incorp. DE
Fiscal Year End May 31
SIC 6794 - Patent Owners and Lessors (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 122335
Cash and cash equivalents 112113
Short-term investments  1 222
Restricted cash and investments 000000
Receivables 0     
Prepaid expense   0000
Other undisclosed current assets 000000
Total current assets: 122335
Noncurrent Assets
Property, plant and equipment 0000 0
Long-term investments and receivables 00001 
Long-term investments 00001 
Other noncurrent assets      0
Other undisclosed noncurrent assets  00   
Total noncurrent assets: 000010
TOTAL ASSETS: 123445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 000000
Accounts payable 000000
Accrued liabilities 000000
Total current liabilities: 000000
Noncurrent Liabilities
Other undisclosed noncurrent liabilities      0
Total noncurrent liabilities:      0
Total liabilities: 000000
Stockholders' equity
Stockholders' equity attributable to parent 122445
Common stock 000000
Treasury stock, value (15)(15)(15)(15)(15)(15)
Additional paid in capital 777777777777
Accumulated deficit (62)(61)(60)(59)(59)(58)
Total stockholders' equity: 122445
TOTAL LIABILITIES AND EQUITY: 123445

Income statement (P&L) ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Gross profit:      0
Operating expenses (1)(1)(1)(1)(2)(1)
Operating loss: (1)(1)(1)(1)(2)(1)
Nonoperating income (expense) (0)(0)(0)10(0)
Investment income, nonoperating   (0)   
Other nonoperating income (expense)   010(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (0)
Loss from continuing operations before equity method investments, income taxes: (1)(1)(1)(0)(1)(2)
Loss from equity method investments      (0)
Loss from continuing operations before income taxes: (1)(1)(1)(0)(1)(2)
Income tax expense (benefit) (0)(0)0(0)(0)(0)
Loss from continuing operations: (1)(1)(1)(0)(1)(2)
Loss from discontinued operations      (0)
Net loss: (1)(1)(1)(0)(1)(2)
Other undisclosed net income attributable to parent      0
Net loss available to common stockholders, diluted: (1)(1)(1)(0)(1)(2)

Comprehensive Income ($ in millions)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Net loss: (1)(1)(1)(0)(1)(2)
Comprehensive loss, net of tax, attributable to parent: (1)(1)(1)(0)(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: